 |
BioWorld-International-2003-03-12
'Nucleic Acid Powerhouse' Built By Cureon, Pantheco Merger
'Nucleic Acid Powerhouse' Built By Cureon, Pantheco Merger
Cureon A/S and Pantheco A/S, two Danish firms that specialize in developing antisense drugs based on DNA analogue chemistry, disclosed plans to merge in a stock-based transaction that would create a "nucleic acid powerhouse" focusing initially on cancer therapy. (BioWorld International)